CN112438397A - 一种供高血糖人群食用的药膳 - Google Patents
一种供高血糖人群食用的药膳 Download PDFInfo
- Publication number
- CN112438397A CN112438397A CN202011435553.1A CN202011435553A CN112438397A CN 112438397 A CN112438397 A CN 112438397A CN 202011435553 A CN202011435553 A CN 202011435553A CN 112438397 A CN112438397 A CN 112438397A
- Authority
- CN
- China
- Prior art keywords
- parts
- hyperglycemia
- medicated diet
- people
- chrysanthemum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000001421 hyperglycemia Diseases 0.000 title claims abstract description 27
- 235000005911 diet Nutrition 0.000 title claims abstract description 17
- 230000037213 diet Effects 0.000 title claims abstract description 17
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 14
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims abstract description 14
- 241000414067 Inonotus obliquus Species 0.000 claims abstract description 14
- 235000009811 Momordica charantia Nutrition 0.000 claims abstract description 14
- 244000179886 Moringa oleifera Species 0.000 claims abstract description 14
- 235000011347 Moringa oleifera Nutrition 0.000 claims abstract description 14
- 240000000249 Morus alba Species 0.000 claims abstract description 14
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 14
- 240000004371 Panax ginseng Species 0.000 claims abstract description 14
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 14
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 14
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 14
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 14
- 235000020235 chia seed Nutrition 0.000 claims abstract description 14
- 235000008434 ginseng Nutrition 0.000 claims abstract description 14
- 240000002624 Mespilus germanica Species 0.000 claims abstract description 13
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 13
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 13
- 241000756042 Polygonatum Species 0.000 claims abstract description 13
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 13
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 12
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 12
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 12
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 12
- 235000009812 Momordica cochinchinensis Nutrition 0.000 claims abstract description 12
- 235000018365 Momordica dioica Nutrition 0.000 claims abstract description 12
- 240000006766 Cornus mas Species 0.000 claims abstract description 9
- 235000017803 cinnamon Nutrition 0.000 claims abstract description 8
- 240000001910 Momordica cochinchinensis Species 0.000 claims abstract 3
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims abstract 2
- 235000008737 Polygonatum biflorum Nutrition 0.000 claims description 8
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 6
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 6
- 235000013399 edible fruits Nutrition 0.000 claims description 5
- 239000008280 blood Substances 0.000 abstract description 18
- 210000004369 blood Anatomy 0.000 abstract description 18
- 238000011282 treatment Methods 0.000 abstract description 8
- 208000024891 symptom Diseases 0.000 abstract description 7
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 6
- 210000004185 liver Anatomy 0.000 abstract description 6
- 230000035922 thirst Effects 0.000 abstract description 6
- 208000006083 Hypokinesia Diseases 0.000 abstract description 5
- 206010013781 dry mouth Diseases 0.000 abstract description 4
- 210000003734 kidney Anatomy 0.000 abstract description 4
- 210000000952 spleen Anatomy 0.000 abstract description 4
- 206010061218 Inflammation Diseases 0.000 abstract description 3
- 208000004880 Polyuria Diseases 0.000 abstract description 3
- 210000001124 body fluid Anatomy 0.000 abstract description 3
- 239000010839 body fluid Substances 0.000 abstract description 3
- 230000023852 carbohydrate metabolic process Effects 0.000 abstract description 3
- 235000012000 cholesterol Nutrition 0.000 abstract description 3
- 206010016256 fatigue Diseases 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 3
- 230000004054 inflammatory process Effects 0.000 abstract description 3
- 210000004072 lung Anatomy 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 238000010791 quenching Methods 0.000 abstract description 3
- 230000001105 regulatory effect Effects 0.000 abstract description 3
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 230000002000 scavenging effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 15
- 244000302512 Momordica charantia Species 0.000 description 11
- 206010012601 diabetes mellitus Diseases 0.000 description 9
- 238000000034 method Methods 0.000 description 7
- 241000723347 Cinnamomum Species 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 201000010099 disease Diseases 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000002218 hypoglycaemic effect Effects 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000012856 packing Methods 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 208000013016 Hypoglycemia Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 240000005717 Dioscorea alata Species 0.000 description 2
- 235000002723 Dioscorea alata Nutrition 0.000 description 2
- 235000007056 Dioscorea composita Nutrition 0.000 description 2
- 235000009723 Dioscorea convolvulacea Nutrition 0.000 description 2
- 235000005362 Dioscorea floribunda Nutrition 0.000 description 2
- 235000004868 Dioscorea macrostachya Nutrition 0.000 description 2
- 235000005361 Dioscorea nummularia Nutrition 0.000 description 2
- 235000005360 Dioscorea spiculiflora Nutrition 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 235000006350 Ipomoea batatas var. batatas Nutrition 0.000 description 2
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 206010008118 cerebral infarction Diseases 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 235000004879 dioscorea Nutrition 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 229960004580 glibenclamide Drugs 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000007711 solidification Methods 0.000 description 2
- 230000008023 solidification Effects 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- 208000016261 weight loss Diseases 0.000 description 2
- XUFXOAAUWZOOIT-SXARVLRPSA-N (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound O([C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O)N[C@@H]1[C@@H]([C@@H](O)[C@H](O)C(CO)=C1)O)C)[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O XUFXOAAUWZOOIT-SXARVLRPSA-N 0.000 description 1
- BOVGTQGAOIONJV-BETUJISGSA-N 1-[(3ar,6as)-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-2-yl]-3-(4-methylphenyl)sulfonylurea Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC(=O)NN1C[C@H]2CCC[C@H]2C1 BOVGTQGAOIONJV-BETUJISGSA-N 0.000 description 1
- LLJFMFZYVVLQKT-UHFFFAOYSA-N 1-cyclohexyl-3-[4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxo-2-isoquinolinyl)ethyl]phenyl]sulfonylurea Chemical compound C=1C(OC)=CC=C(C(C2=O)(C)C)C=1C(=O)N2CCC(C=C1)=CC=C1S(=O)(=O)NC(=O)NC1CCCCC1 LLJFMFZYVVLQKT-UHFFFAOYSA-N 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 229940124213 Dipeptidyl peptidase 4 (DPP IV) inhibitor Drugs 0.000 description 1
- HTQBXNHDCUEHJF-XWLPCZSASA-N Exenatide Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 HTQBXNHDCUEHJF-XWLPCZSASA-N 0.000 description 1
- 108010011459 Exenatide Proteins 0.000 description 1
- FAEKWTJYAYMJKF-QHCPKHFHSA-N GlucoNorm Chemical compound C1=C(C(O)=O)C(OCC)=CC(CC(=O)N[C@@H](CC(C)C)C=2C(=CC=CC=2)N2CCCCC2)=C1 FAEKWTJYAYMJKF-QHCPKHFHSA-N 0.000 description 1
- 239000009022 Jinqi Substances 0.000 description 1
- 206010023379 Ketoacidosis Diseases 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- 108010019598 Liraglutide Proteins 0.000 description 1
- YSDQQAXHVYUZIW-QCIJIYAXSA-N Liraglutide Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCC)C(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=C(O)C=C1 YSDQQAXHVYUZIW-QCIJIYAXSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- IBAQFPQHRJAVAV-ULAWRXDQSA-N Miglitol Chemical compound OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO IBAQFPQHRJAVAV-ULAWRXDQSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- GHUUBYQTCDQWRA-UHFFFAOYSA-N Pioglitazone hydrochloride Chemical compound Cl.N1=CC(CC)=CC=C1CCOC(C=C1)=CC=C1CC1C(=O)NC(=O)S1 GHUUBYQTCDQWRA-UHFFFAOYSA-N 0.000 description 1
- 241001633680 Polygonatum odoratum Species 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- 229940123464 Thiazolidinedione Drugs 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 229960002632 acarbose Drugs 0.000 description 1
- XUFXOAAUWZOOIT-UHFFFAOYSA-N acarviostatin I01 Natural products OC1C(O)C(NC2C(C(O)C(O)C(CO)=C2)O)C(C)OC1OC(C(C1O)O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O XUFXOAAUWZOOIT-UHFFFAOYSA-N 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 150000004283 biguanides Chemical class 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 239000003603 dipeptidyl peptidase IV inhibitor Substances 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960001519 exenatide Drugs 0.000 description 1
- 229960000346 gliclazide Drugs 0.000 description 1
- 229960004346 glimepiride Drugs 0.000 description 1
- WIGIZIANZCJQQY-RUCARUNLSA-N glimepiride Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)N[C@@H]2CC[C@@H](C)CC2)C=C1 WIGIZIANZCJQQY-RUCARUNLSA-N 0.000 description 1
- 229960003468 gliquidone Drugs 0.000 description 1
- 239000003877 glucagon like peptide 1 receptor agonist Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000011337 individualized treatment Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229960002701 liraglutide Drugs 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 1
- 229960003105 metformin Drugs 0.000 description 1
- 229960001110 miglitol Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 229960000698 nateglinide Drugs 0.000 description 1
- OELFLUMRDSZNSF-BRWVUGGUSA-N nateglinide Chemical compound C1C[C@@H](C(C)C)CC[C@@H]1C(=O)N[C@@H](C(O)=O)CC1=CC=CC=C1 OELFLUMRDSZNSF-BRWVUGGUSA-N 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- ICFJFFQQTFMIBG-UHFFFAOYSA-N phenformin Chemical compound NC(=N)NC(=N)NCCC1=CC=CC=C1 ICFJFFQQTFMIBG-UHFFFAOYSA-N 0.000 description 1
- 229960003243 phenformin Drugs 0.000 description 1
- 229960002827 pioglitazone hydrochloride Drugs 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 229960002354 repaglinide Drugs 0.000 description 1
- 229960003271 rosiglitazone maleate Drugs 0.000 description 1
- SUFUKZSWUHZXAV-BTJKTKAUSA-N rosiglitazone maleate Chemical compound [H+].[H+].[O-]C(=O)\C=C/C([O-])=O.C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O SUFUKZSWUHZXAV-BTJKTKAUSA-N 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 229960004034 sitagliptin Drugs 0.000 description 1
- MFFMDFFZMYYVKS-SECBINFHSA-N sitagliptin Chemical compound C([C@H](CC(=O)N1CC=2N(C(=NN=2)C(F)(F)F)CC1)N)C1=CC(F)=C(F)C=C1F MFFMDFFZMYYVKS-SECBINFHSA-N 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000009168 stem cell therapy Methods 0.000 description 1
- 238000009580 stem-cell therapy Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 150000001467 thiazolidinediones Chemical class 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 229960001254 vildagliptin Drugs 0.000 description 1
- SYOKIDBDQMKNDQ-XWTIBIIYSA-N vildagliptin Chemical compound C1C(O)(C2)CC(C3)CC1CC32NCC(=O)N1CCC[C@H]1C#N SYOKIDBDQMKNDQ-XWTIBIIYSA-N 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
一种供高血糖人群食用的药膳，涉及药膳领域，解决了现有几种高血糖治疗方案存在的问题。本发明按重量份数计包括：人参1000～3000份、葛根1000～3000份、桑叶1000～3000份、苦瓜1000～3000份、枸杞1000～3000份、玉竹1000～3000份、山药1000～3000份、肉桂1000～3000份、菊花1000～3000份、山茱萸1000～2000份、奇亚籽1000～3000份、辣木叶1000～3000份、桦褐孔菌1000～3000份。本发明能大补元气、养阴润燥、补益肝肾、补脾益肺、生津止渴、通经活络；祛湿热、平衡血糖、调节糖代谢、降低胆固醇、减轻炎症、清除体内自由基、增强免疫力；改善高血糖导致的口渴、口干、倦怠乏力、多尿等不适症状，降低高血糖并发症的发病率。
Description
技术领域
本发明涉及一种药膳，具体涉及一种供高血糖人群食用的药膳。
背景技术
简单来说，高血糖就是体内血糖升高超过正常阈值的情况。而一旦血糖浓度等值超出了正常范围以及体内的调节体制所能应对的情况，就相当于打破了身体的平衡状态，可能会导致许多问题，如出现口渴、多饮、多尿、乏力、体重减轻等症状；长期的高血糖则会使全身各个组织器官发生病变，引发糖尿病、酮症酸中毒、肥胖症、心脏病、脑梗、白内障、骨质疏松等疾病。因此，一旦出现血糖异常升高的情况，就应该及时确诊、尽早治疗，否则会严重影响患者的正常生活，长此以往，还有可能引发各种并发症，增加致残率，甚至危及患者的生命。
从中医的观点分析，高血糖不是一种疾病的诊断，在中医学无明确的病名，属中医学的“消渴”范畴，病变与阴虚、五脏虚弱等相关，“脾虚”、“肝气郁结”、“痰湿”、“血瘀”、“肾虚”、“气虚”等都是其发病的重要因素。中医临床诊治消渴的基本原则是“辨证论治”，强调因人而异的个体化治疗，意在标本兼治。而标本兼治，其本在气虚、阴虚，其标在燥热、瘀血、痰浊、肝郁、湿热、痰湿。其虚又有不同脏腑之分，其实又可兼见出现，故临床所见证型复杂多样。常用的降血糖中成药有金芪降糖片、玉泉丸、消渴丸等。
目前针对高血糖，中医辨证论治固然可取，但由于辨证分型标准不统一，证型复杂多样等原因，严重影响了中医临床规范治疗高血糖的效果。
至于西医治疗，目前用于降血糖的药物有很多，主要分为以下几种：
1.口服药物：
①磺酰脲类：格列苯脲、格列齐特、格列美脲、格列喹酮等。
②双胍类：二甲双胍、苯乙双胍等。
③α-葡萄糖苷酶抑制剂：阿卡波糖、米格列醇等。
④噻唑烷二酮类：马来酸罗格列酮、盐酸吡格列酮等。
⑤格列奈类促胰岛素分泌剂：瑞格列奈、那格列奈等。
⑥二肽基肽酶-4抑制剂：西格列汀、维格列汀等。
2.胰高血糖素样肽-1受体激动剂：艾塞那肽、利拉鲁肽等。
3.胰岛素
除了药物治疗外，西医还有手术治疗、干细胞治疗、胰腺移植、胰岛细胞移植等，但这些疗法还没有全面铺开，其长期疗效有待进一步临床研究。
而西医药物治疗在降糖作用明显，疗效确切的同时，其副作用亦多见，如低血糖反应、胃肠道不适、肝肾功能损害等。在使用降糖药物时，应严格控制药物用量，一旦用量过大就会导致低血糖，低血糖同样会对身体不利，出现头晕、乏力等症状，严重的时候还可能会引起休克。
发明内容
为了解决中西药在治疗高血糖疾病中存在的诸多问题，本发明提供了一种供高血糖人群食用的药膳。
本发明为解决技术问题所采用的技术方案如下：
本发明的一种供高血糖人群食用的药膳，按照重量份数计包括以下组份：
人参1000～3000份、葛根1000～3000份、桑叶1000～3000份、苦瓜1000～3000份、枸杞1000～3000份、玉竹1000～3000份、山药1000～3000份、肉桂1000～3000份、菊花1000～3000份、山茱萸1000～2000份、奇亚籽1000～3000份、辣木叶1000～3000份、桦褐孔菌1000～3000份。
作为优选的实施方式，本发明的一种供高血糖人群食用的药膳，按照重量份数计包括以下组份：
人参1500份、葛根1500份、桑叶1500份、苦瓜1500份、构杞1500份、玉竹1500份、山药1500份、肉桂1500份、菊花1500份、山茱萸1000份、奇亚籽1500份、辣木叶2000份、桦褐孔菌2000份。
本发明的有益效果是：
本发明是由人参、葛根、桑叶、枸杞、玉竹、山药、肉桂、菊花、山茱萸九味食药物质组成，诸品合用，有大补元气、养阴润燥、补益肝肾、补脾益肺、生津止渴、通经活络的作用；以桦褐孔菌、辣木叶、苦瓜、奇亚籽这些食品原料组成，能够祛湿热、平衡血糖、调节糖代谢、降低胆固醇、减轻炎症、清除体内自由基、增强免疫力。
经过十几年来的临床验证证明，本发明的一种供高血糖人群食用的药膳可改善高血糖导致的口渴、口干、倦怠乏力、多尿等不适症状，降低高血糖并发症的发病率。
另外，本发明所使用的食药物质和营养强化物质安全、无毒副作用。
具体实施方式
本发明的一种供高血糖人群食用的药膳，按照重量份数计包括以下组份：
人参1000～3000份、葛根1000～3000份、桑叶1000～3000份、苦瓜1000～3000份、枸杞1000～3000份、玉竹1000～3000份、山药1000～3000份、肉桂1000～3000份、菊花1000～3000份、山茱萸1000～2000份、奇亚籽1000～3000份、辣木叶1000～3000份、桦褐孔菌1000～3000份。
本发明中各组份的作用及功效如下：
本发明由人参、葛根、桑叶、枸杞、玉竹、山药、肉桂、菊花、山茱萸九味食药物质组成，诸品合用，有大补元气、养阴润燥、补益肝肾、补脾益肺、生津止渴、通经活络的作用。
本发明以桦褐孔菌、辣木叶、苦瓜、奇亚籽组成精准营养强化部分，能够祛湿热、平衡血糖、调节糖代谢、降低胆固醇、减轻炎症、清除体内自由基、增强免疫力。
本发明的一种供高血糖人群食用的药膳的制备方法具体包括以下步骤：
①按照本发明的组份及用量称取原料备用；
②将全部原料依次投入混料机内，混合均匀，以没有结块、结固为准，密封备用；
③将混匀后的复合粉投入真空干燥机内进行干燥；
④取样检测重金属、微生物；
⑤检测不合格的混料，按原因进行重新处理；合格的混料进行分装；
⑥分装后的产品进入外包装室进行外包装；
⑦现场进行质量检验，合格后入库。
本发明的一种供高血糖人群食用的药膳的食用方法：
取本品1袋，温水冲泡，搅拌均匀，待温度适宜后即可食用。每次1袋，每日2次。
下面将结合本发明实施例，对本发明实施例中的技术方案进行清楚、完整地描述，显然，所描述的实施例仅仅是本发明一部分实施例，而不是全部的实施例。基于本发明中的实施例，本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例，都属于本发明保护的范围。
实施例1
本实施例的具体组份及用量如下：
人参1500份、葛根1500份、桑叶1500份、苦瓜1500份、枸杞1500份、玉竹1500份、山药1500份、肉桂1500份、菊花1500份、山茱萸1000份、奇亚籽1500份、辣木叶2000份、桦褐孔菌2000份。
本实施例的制备过程如下：
①按照本发明的组份及用量称取原料备用；
②将全部原料依次投入混料机内，混合均匀，以没有结块、结固为准，密封备用；
③将混匀后的复合粉投入真空干燥机内进行干燥；
④取样检测重金属、微生物；
⑤检测不合格的混料，按原因进行重新处理；合格的混料进行分装；
⑥分装后的产品进入外包装室进行外包装；
⑦现场进行质量检验，合格后入库。
实施例2
本实施例的具体组份及用量如下：
人参1300份、葛根1600份、桑叶1500份、苦瓜1400份、枸杞1600份、玉竹1300份、山药1600份、肉桂1500份、菊花1400份、山茱萸1000份、奇亚籽1800份、辣木叶2000份、桦褐孔菌2000份。
本实施例的制备过程与实施例1相同。
实施例3
本实施例的具体组份及用量如下：
人参1350份、葛根1500份、桑叶1500份、苦瓜1550份、枸杞1500份、玉竹1500份、山药1550份、肉桂1450份、菊花1500份、山茱萸1050份、奇亚籽1400份、辣木叶2050份、桦褐孔菌2100份。
本实施例的制备过程与实施例1相同。
实施例4
本实施例的具体组份及用量如下：
人参1200份、葛根1450份、桑叶1400份、苦瓜1450份、枸杞1500份、玉竹1550份、山药1450份、肉桂1550份、菊花1500份、山茱萸1100份、奇亚籽1600份、辣木叶2100份、桦褐孔菌2150份。
本实施例的制备过程与实施例1相同。
实施例5
本实施例的具体组份及用量如下：
人参1000份、葛根1500份、桑叶1600份、苦瓜1500份、枸杞1450份、玉竹1400份、山药1500份、肉桂1450份、菊花1450份、山茱萸1250份、奇亚籽1650份、辣木叶2200份、桦褐孔菌2050份。
本实施例的制备过程与实施例1相同。
实施例6
本实施例的具体组份及用量如下：
人参1050份、葛根1550份、桑叶1550份、苦瓜1500份、枸杞1500份、玉竹1400份、山药1650份、肉桂1550份、菊花1550份、山茱萸1200份、奇亚籽1500份、辣木叶2150份、桦褐孔菌1850份。
本实施例的制备过程与实施例1相同。
临床试验
案例1：高血糖
患者姓名：姚某某
年龄：31岁
性别：男
职业：公司职员
医院诊断：糖尿病、肝病
2017年5月确诊为糖尿病，6月份开始胰岛素注射治疗。从18年开始自购保健品调理血糖，效果不理想，出现了眼花、腰疼、乏力、体重下降等不适症状，血糖也飙升至19.9mmol/L。在2018年8月开始服用本发明，服用6个月后，体重增加，气色好了很多，眼花、腰疼、乏力的情况有所缓解；2019年4月，血糖基本已经稳定，空腹血糖在12mmol/L左右。
案例2：高血糖
患者姓名：何某某
年龄：79岁
性别：女
职业：退休
医院诊断：糖尿病，皮肤瘙痒
十余年的糖尿病病史，总是口干，皮肤瘙痒，饮食、睡眠尚可。于2020年5月份开始服用本发明，坚持服用6个月后，测量血糖，空腹血糖基本稳定在6～8mmol/L左右，皮肤瘙痒、口干的情况有所缓解，自身免疫力有所提高。
案例3：高血糖
患者姓名：李某某
年龄：50岁
性别：男
职业：退休
医院诊断：糖尿病并发腿脚不便、脑梗
患者于2020年1月住院就诊，不仅视物不清，腿脚不便，还乏力，整个人没有什么精神，不太爱说话。2020年3月开始服用本发明，服用6个月后，视力有所改善，腿脚的情况也有所好转，精气神提起来了，心情也越来越好，渐渐愿意与人交流，空腹血糖基本稳定在7～9mmol/L左右，生活质量大大提高。
本发明公开了一种供高血糖人群食用的药膳，本领域技术人员可以借鉴本文内容，适当改进工艺参数实现。特别需要指出的是，所有类似的替换和改动对本领域技术人员来说是显而易见的，它们都被视为包括在本发明。本发明的产品已经通过较佳实施例进行了描述，相关人员明显能在不脱离本发明内容、精神和范围内对本文所述的产品进行改动或适当变更与组合，来实现和应用本发明技术。
Claims (2)
1.一种供高血糖人群食用的药膳，其特征在于，按照重量份数计包括以下组份：
人参1000～3000份、葛根1000～3000份、桑叶1000～3000份、苦瓜1000～3000份、枸杞1000～3000份、玉竹1000～3000份、山药1000～3000份、肉桂1000～3000份、菊花1000～3000份、山茱萸1000～2000份、奇亚籽1000～3000份、辣木叶1000～3000份、桦褐孔菌1000～3000份。
2.根据权利要求1所述的一种供高血糖人群食用的药膳，其特征在于，按照重量份数计包括以下组份：
人参1500份、葛根1500份、桑叶1500份、苦瓜1500份、枸杞1500份、玉竹1500份、山药1500份、肉桂1500份、菊花1500份、山茱萸1000份、奇亚籽1500份、辣木叶2000份、桦褐孔菌2000份。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011435553.1A CN112438397A (zh) | 2020-12-11 | 2020-12-11 | 一种供高血糖人群食用的药膳 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011435553.1A CN112438397A (zh) | 2020-12-11 | 2020-12-11 | 一种供高血糖人群食用的药膳 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112438397A true CN112438397A (zh) | 2021-03-05 |
Family
ID=74739422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011435553.1A Pending CN112438397A (zh) | 2020-12-11 | 2020-12-11 | 一种供高血糖人群食用的药膳 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112438397A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113243531A (zh) * | 2021-06-02 | 2021-08-13 | 膳行天下(吉林)科技发展有限公司 | 一种供高尿酸人群食用的药膳 |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101181515A (zh) * | 2006-11-14 | 2008-05-21 | 李献国 | 一种降血糖保健药品及其制备方法 |
| CN104256009A (zh) * | 2014-09-27 | 2015-01-07 | 山东吴氏恒康健康科技有限公司 | 葛根桑葚子茶及其制备方法 |
| CN106901367A (zh) * | 2017-03-14 | 2017-06-30 | 张勇 | 一种平衡血糖的组合物以及制备方法和用途 |
| CN107468898A (zh) * | 2017-09-11 | 2017-12-15 | 邹立影 | 一种糖尿病患者专用食品及其制作方法 |
| CN109907264A (zh) * | 2019-04-12 | 2019-06-21 | 吉林省九圣源生物科技有限公司 | 一种供感冒人群食用的药膳 |
| CN110772602A (zh) * | 2019-11-08 | 2020-02-11 | 李本强 | 一种糖尿病用中药药膳 |
-
2020
- 2020-12-11 CN CN202011435553.1A patent/CN112438397A/zh active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101181515A (zh) * | 2006-11-14 | 2008-05-21 | 李献国 | 一种降血糖保健药品及其制备方法 |
| CN104256009A (zh) * | 2014-09-27 | 2015-01-07 | 山东吴氏恒康健康科技有限公司 | 葛根桑葚子茶及其制备方法 |
| CN106901367A (zh) * | 2017-03-14 | 2017-06-30 | 张勇 | 一种平衡血糖的组合物以及制备方法和用途 |
| CN107468898A (zh) * | 2017-09-11 | 2017-12-15 | 邹立影 | 一种糖尿病患者专用食品及其制作方法 |
| CN109907264A (zh) * | 2019-04-12 | 2019-06-21 | 吉林省九圣源生物科技有限公司 | 一种供感冒人群食用的药膳 |
| CN110772602A (zh) * | 2019-11-08 | 2020-02-11 | 李本强 | 一种糖尿病用中药药膳 |
Non-Patent Citations (1)
| Title |
|---|
| 陈瑞娇 等: "辣木叶总黄酮的提取及其降血糖作用" * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113243531A (zh) * | 2021-06-02 | 2021-08-13 | 膳行天下(吉林)科技发展有限公司 | 一种供高尿酸人群食用的药膳 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102150692B (zh) | 一种具有治疗糖尿病功能的饼干及其制备方法 | |
| US10894070B2 (en) | Drug compound for the control of blood glucose, blood lipids and weight | |
| CN108524673A (zh) | 一种中药组合物及其应用 | |
| CN112438397A (zh) | 一种供高血糖人群食用的药膳 | |
| CN102579655A (zh) | 治疗口腔溃疡的中药外敷制剂 | |
| CN103977194A (zh) | 能有效治疗创面感染的外用药在制备治疗糖尿病足药物中的应用 | |
| CN110917272A (zh) | 一种治愈糖尿病及其并发症的中药组方 | |
| WO2018040008A1 (zh) | 一种用于治疗糖尿病的生物中药内服药及其制备方法 | |
| CN102872423A (zh) | 一种治疗糖尿病的中药组合物及其制备方法 | |
| CN102406711A (zh) | 一种治疗糖尿病的药物 | |
| CN104324261A (zh) | 治疗高血糖的药物组合物及其制备方法 | |
| WO2021007934A1 (zh) | 五谷虫浸酒制品在用于治疗糖尿病中的应用 | |
| CN104001003A (zh) | 一种治疗糖尿病的口服液和舌下喷剂 | |
| US8226990B2 (en) | Composition for treatment of diabetes mellitus and a preparation and an use thereof | |
| WO2021007933A1 (zh) | 五谷虫在用于治疗糖尿病中的应用 | |
| CN104225228B (zh) | 一种用于调节血糖的中药制剂 | |
| CN106729304B (zh) | 一种减轻禁食或节食副反应的中药及其制备方法 | |
| CN113144084A (zh) | 一种治疗频发室性早搏的中药组合物及其应用 | |
| CN110507707A (zh) | 一种治疗ⅱ型糖尿病的中药组合物及其制备方法 | |
| CN105031248A (zh) | 一种含有硒虫草的可辅助降血糖的保健品 | |
| KR20050086788A (ko) | 파파야 퓌레 및 그의 용도 | |
| CN108114268A (zh) | 一种降低血糖的中药组合物、制剂及其制备方法与应用 | |
| CN111939203B (zh) | 一种治疗糖尿病足中药软膏制剂及其制备方法 | |
| CN102366443B (zh) | 一种治疗糖尿病的药物及其制备方法 | |
| CN110679947A (zh) | 一种降血糖中药保健品 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20210305 |